NEONC TECHNOLOGIES HOLDINGS (NTHI) Stock Fundamental Analysis

NASDAQ:NTHI • US64051A1016

9.95 USD
+1.35 (+15.7%)
Last: Feb 20, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NTHI. NTHI was compared to 192 industry peers in the Pharmaceuticals industry. NTHI has a bad profitability rating. Also its financial health evaluation is rather negative. NTHI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • NTHI had negative earnings in the past year.
  • In the past year NTHI has reported a negative cash flow from operations.
NTHI Yearly Net Income VS EBIT VS OCF VS FCFNTHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -5M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1197.07%, NTHI is doing worse than 95.83% of the companies in the same industry.
Industry RankSector Rank
ROA -1197.07%
ROE N/A
ROIC N/A
ROA(3y)-648.49%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NTHI Yearly ROA, ROE, ROICNTHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 200 -200 -400 -600 -800 -1K

1.3 Margins

  • NTHI's Gross Margin of 138.33% is amongst the best of the industry. NTHI outperforms 98.96% of its industry peers.
  • The Profit Margin and Operating Margin are not available for NTHI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 138.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NTHI Yearly Profit, Operating, Gross MarginsNTHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • NTHI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • NTHI has about the same amout of shares outstanding than it did 1 year ago.
  • There is no outstanding debt for NTHI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NTHI Yearly Shares OutstandingNTHI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M
NTHI Yearly Total Debt VS Total AssetsNTHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • Based on the Altman-Z score of -67.42, we must say that NTHI is in the distress zone and has some risk of bankruptcy.
  • NTHI has a worse Altman-Z score (-67.42) than 92.71% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -67.42
ROIC/WACCN/A
WACC9.24%
NTHI Yearly LT Debt VS Equity VS FCFNTHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 -2M -4M -6M -8M -10M

2.3 Liquidity

  • NTHI has a Current Ratio of 0.19. This is a bad value and indicates that NTHI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NTHI has a worse Current ratio (0.19) than 94.27% of its industry peers.
  • NTHI has a Quick Ratio of 0.19. This is a bad value and indicates that NTHI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NTHI's Quick ratio of 0.19 is on the low side compared to the rest of the industry. NTHI is outperformed by 93.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
NTHI Yearly Current Assets VS Current LiabilitesNTHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • NTHI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.26%, which is quite impressive.
  • Looking at the last year, NTHI shows a quite strong growth in Revenue. The Revenue has grown by 17.73% in the last year.
EPS 1Y (TTM)20.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-284.98%
Revenue 1Y (TTM)17.73%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • NTHI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -54.22% yearly.
  • The Revenue is expected to decrease by -41.42% on average over the next years. This is quite bad
EPS Next YN/A
EPS Next 2Y-54.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

NTHI Yearly Revenue VS EstimatesNTHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 20K 40K 60K 80K
NTHI Yearly EPS VS EstimatesNTHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NTHI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NTHI Price Earnings VS Forward Price EarningsNTHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NTHI Per share dataNTHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2 -2.5

4.3 Compensation for Growth

  • NTHI's earnings are expected to decrease with -54.22% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-54.22%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • NTHI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NEONC TECHNOLOGIES HOLDINGS

NASDAQ:NTHI (2/20/2026, 8:00:01 PM)

9.95

+1.35 (+15.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-17
Earnings (Next)05-07
Inst Owners9.21%
Inst Owner Change17.95%
Ins Owners50.16%
Ins Owner Change15.61%
Market Cap193.73M
Revenue(TTM)60.00K
Net Income(TTM)-48.88M
AnalystsN/A
Price TargetN/A
Short Float %3.48%
Short Ratio2.59
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3228.77
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.59
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.91
FCFYN/A
OCF(TTM)-0.91
OCFYN/A
SpS0
BVpS-0.61
TBVpS-0.61
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1197.07%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 138.33%
FCFM N/A
ROA(3y)-648.49%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z -67.42
F-ScoreN/A
WACC9.24%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-284.98%
EPS Next YN/A
EPS Next 2Y-54.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.73%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-124.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-124.14%
OCF growth 3YN/A
OCF growth 5YN/A

NEONC TECHNOLOGIES HOLDINGS / NTHI FAQ

Can you provide the ChartMill fundamental rating for NEONC TECHNOLOGIES HOLDINGS?

ChartMill assigns a fundamental rating of 1 / 10 to NTHI.


What is the valuation status for NTHI stock?

ChartMill assigns a valuation rating of 0 / 10 to NEONC TECHNOLOGIES HOLDINGS (NTHI). This can be considered as Overvalued.


How profitable is NEONC TECHNOLOGIES HOLDINGS (NTHI) stock?

NEONC TECHNOLOGIES HOLDINGS (NTHI) has a profitability rating of 1 / 10.